323 related articles for article (PubMed ID: 17938813)
1. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
Oishi K; Ohkura N; Matsuda J; Ishida N
Thromb Haemost; 2007 Oct; 98(4):864-70. PubMed ID: 17938813
[TBL] [Abstract][Full Text] [Related]
2. PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice.
Oishi K; Tomita T; Itoh N; Ohkura N
Thromb Res; 2011 Nov; 128(5):e81-5. PubMed ID: 21757225
[TBL] [Abstract][Full Text] [Related]
3. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
4. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
Kitagawa N; Yano Y; Gabazza EC; Bruno NE; Araki R; Matsumoto K; Katsuki A; Hori Y; Nakatani K; Taguchi O; Sumida Y; Suzuki K; Adachi Y
Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
[TBL] [Abstract][Full Text] [Related]
5. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
8. Functional role of the fibrinolytic system in development of adipose tissue.
Lijnen HR
Verh K Acad Geneeskd Belg; 2009; 71(3):101-13. PubMed ID: 20088250
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
10. The fat mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM.
Samad F; Loskutoff DJ
Thromb Haemost; 1997 Jul; 78(1):652-5. PubMed ID: 9198233
[TBL] [Abstract][Full Text] [Related]
11. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
12. Fat cell function and fibrinolysis.
Alessi MC; Morange P; Juhan-Vague I
Horm Metab Res; 2000; 32(11-12):504-8. PubMed ID: 11246816
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.
Mertens I; Van der Planken M; Corthouts B; Wauters M; Peiffer F; De Leeuw I; Van Gaal L
Horm Metab Res; 2001 Oct; 33(10):602-7. PubMed ID: 11607880
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.
Li JQ; Zhao SP; Li QZ; Cai YC; Wu LR; Fang Y; Li P
Clin Chim Acta; 2006 Aug; 370(1-2):57-62. PubMed ID: 16507303
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
[TBL] [Abstract][Full Text] [Related]
18. Ketogenic diet disrupts the circadian clock and increases hypofibrinolytic risk by inducing expression of plasminogen activator inhibitor-1.
Oishi K; Uchida D; Ohkura N; Doi R; Ishida N; Kadota K; Horie S
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1571-7. PubMed ID: 19628783
[TBL] [Abstract][Full Text] [Related]
19. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids.
Huber J; Löffler M; Bilban M; Reimers M; Kadl A; Todoric J; Zeyda M; Geyeregger R; Schreiner M; Weichhart T; Leitinger N; Waldhäusl W; Stulnig TM
Int J Obes (Lond); 2007 Jun; 31(6):1004-13. PubMed ID: 17130847
[TBL] [Abstract][Full Text] [Related]
20. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
Oishi K; Ohkura N; Amagai N; Ishida N
FEBS Lett; 2005 Jul; 579(17):3555-9. PubMed ID: 15950223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
